Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apyx Medical CorpAPYX · Entity 6609 | Chief Operating Officer | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apyx Medical Corp
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The Roman Family Revocable Trust | 15,000 |
Reported balance
After 2026-06-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-15 · Exercise / conversion · Acquired 15,000 · Balance 15,000 F1: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. |
| Common StockSEC Table I · non-derivative | IndirectBy The Roman Family Revocable Trust | 16,467 |
Reported balance
After 2026-06-15 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-15 · Tax withholding · Disposed 10,533 · Balance 16,467 F1: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.23 · Expires 2027-05-01 | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-15 · Exercise / conversion · Disposed 15,000 · Balance 0 F2: On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.
F2: On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 17, 2026 21:15 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001493152-26-029122 · ownership.xml · derivative · entry 3 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2027-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:15 UTC | Apyx Medical Corp APYX · Entity 6609 | Tax withholdingCommon Stock | 10,533 | $4.60 | $48,451.80 |
DisclosureSEC source: 0001493152-26-029122 · ownership.xml · nonDerivative · entry 2 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By The Roman Family Revocable Trust Disclosed balance after: 16,467 F1 · ownership.nature: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:15 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 15,000 | $3.23 | $48,450.00 |
DisclosureSEC source: 0001493152-26-029122 · ownership.xml · nonDerivative · entry 1 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By The Roman Family Revocable Trust Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 23:00 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 88,044 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001493152-26-028769 · ownership.xml · derivative · entry 1 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,044 Underlying: Common Stock · 88,044 shares Expires 2036-06-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 22:21 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001493152-26-004254 · ownership.xml · derivative · entry 2 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On January 27, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 12,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 22:21 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 12,000 | $1.80 | $21,600.00 |
DisclosureSEC source: 0001493152-26-004254 · ownership.xml · nonDerivative · entry 1 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By The Roman Family Revocable Trust Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:07 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 100,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001493152-25-002766 · ownership.xml · derivative · entry 1 Roman Shawn David · CIK 0002048672 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-01-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.